Business Wire

Bovie Medical Corporation to Release First Quarter of Fiscal Year 2018 Financial Results on May 14, 2018

CLEARWATER, Fla.--(BUSINESS WIRE)--Bovie Medical (NYSE: BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that financial ...
Business Wire

Bovie Medical Corporation Files 510(k) Submission with the FDA for a New Indication to Market and Sell J-Plasma/Renuvion for Use in Dermal Resurfacing Procedures

CLEARWATER, Fla.--(BUSINESS WIRE)--Bovie Medical Corporation (NYSE:BVX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma ®, a patented surgical product marketed ...
FierceBiotech

Bovie bags FDA clearance for surgical device

FDA has granted 510(k) clearance to Bovie Medical’s revamped J-Plasma generator and handpiece. The model combines the J-Plasma technology Bovie sees as a more precise way to perform procedures with ...
Yahoo

Bovie Medical receives 510K clearances to market J-Plasma technology

Bovie Medical announced that the company received 510k clearance from the Food and Drug Administration to market its J-Plasma handpiece with retractable cutting feature for soft tissue coagulation ...
Seeking Alpha

Bovie Medical Corporation's (BVX) CEO Rob Gershon on Q4 2016 Results - Earnings Call Transcript

Good afternoon and welcome to the Bovie Medical Corporation Fourth Quarter 2016 Earnings Conference Call. All participants will be in a listen-only mode. Hosting today's call will be Mr. Rob Gershon, ...